Cargando…
Antiviral anticoagulation
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a novel envelope virus that causes coronavirus disease 2019 (COVID‐19). Hallmarks of COVID‐19 are a puzzling form of thrombophilia that has elevated D‐dimer but only modest effects on other parameters of coagulopathy. This is combined w...
Autores principales: | Pryzdial, Edward L. G., Sutherland, Michael R., Lin, Bryan H., Horwitz, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354393/ https://www.ncbi.nlm.nih.gov/pubmed/32685886 http://dx.doi.org/10.1002/rth2.12406 |
Ejemplares similares
-
Virus–Platelet Associations
por: Pryzdial, Edward L. G., et al.
Publicado: (2017) -
Thrombin A-Chain: Activation Remnant or Allosteric Effector?
por: Carter, Isis S. R., et al.
Publicado: (2010) -
Coagulation and complement: Key innate defense participants in a seamless web
por: Pryzdial, Edward L. G., et al.
Publicado: (2022) -
A biochemical network can control formation of a synthetic material by sensing numerous specific stimuli
por: Hun Yeon, Ju, et al.
Publicado: (2015) -
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
por: Roguljić, Hrvoje, et al.
Publicado: (2022)